The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Insights into Cystic Fibrosis Polymicrobial Consortia: The Role of Species Interactions in Biofilm Development, Phenotype, and Response to In-Use Antibiotics
Open accessAbstract
Cystic Fibrosis (CF) airways disease involves complex polymicrobial infections where different bacterial species can interact and influence each other and/or even interfere with the whole community. To gain insights into the role that interactions between Pseudomonas aeruginosa in co-culture with Staphylococcus aureus, Inquilinus limosus and Stenotrophomonas maltophilia may play in infection, the reciprocal effect during biofilm formation and the response of dual biofilms towards ciprofloxacin under in vitro atmospheres with different oxygen availabilities were evaluated. Biofilm formation kinetics showed that the growth of S. aureus, I. limosus and S. maltophilia was disturbed in the presence of P. aeruginosa, under both aerobic and anaerobic environments. On the other hand, under aerobic conditions, I. limosus led to a decrease in biofilm mass production by P. aeruginosa, although biofilm-cells viability remains unaltered. The interaction between S. maltophilia and P. aeruginosa positively influenced dual biofilm development by increasing its biomass. Compared with monocultures, biomass of P. aeruginosa + S. aureus biofilms was significantly reduced by reciprocal interference. When grown in dual biofilms with P. aeruginosa, ciprofloxacin was less effective against S. aureus, I. limosus and S. maltophilia, with increasing antibiotic doses leading to drastic inhibitions of P. aeruginosa cultivability. Therefore, P. aeruginosa might be responsible for the protection of the whole dual consortia against ciprofloxacin activity. Based on the overall data, it can be speculated that reciprocal interferences occur between the different bacterial species in CF lung, regardless the level of oxygen. The findings also suggest that alterations of bacterial behaviour due to species interplay may be important for disease progression in CF infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial competition: surviving and thriving in the microbial jungle
Hibbing, M. E., Fuqua, C., Parsek, M. R., & Peterson, S. B. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2259 · Cited by 2,689
A modified microtiter-plate test for quantification of staphylococcal biofilm formation
Stepanović, S., Vuković, D., Dakić, I., Savić, B., & Švabić-Vlahović, M. (2000) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(00)00122-6 · Cited by 2,550
Nährlich, L., Mainz, J. G., Adams, C., Engel, C., Herrmann, G., Icheva, V., Lauer, J., Deppisch, C., Wirth, A., Unger, K., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350071 · Cited by 2,525
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
The clinical impact of bacterial biofilms
Høiby, N., Ciofu, O., Johansen, H. K., Song, Z., Moser, C., Jensen, P. Ø., Molin, S., Givskov, M., Tolker‐Nielsen, T., & Bjarnsholt, T. (2011) · International Journal of Oral Science · doi:10.4248/ijos11026 · Cited by 894
General Principles of Antimicrobial Therapy
Leekha, S., Terrell, C. L., & Edson, R. S. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0639 · Cited by 878
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., & Høiby, N. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21011 · Cited by 795
Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution
(2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00790.x · Cited by 735
Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution
(2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00142.x · Cited by 599
Hoffman, L. R., Déziel, E., D'Argenio, D. A., Lépine, F., Emerson, J., McNamara, S., Gibson, R. L., Ramsey, B. W., & Miller, S. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606756104 · Cited by 467
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Goss, C. H., & Burns, J. L. (2007) · Thorax · doi:10.1136/thx.2006.060889 · Cited by 445
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Amin, R., Dupuis, A., Aaron, S. D., & Ratjen, F. (2010) · Chest · doi:10.1378/chest.09-1103 · Cited by 376
Microbial ecology of the cystic fibrosis lung
Harrison, F. (2007) · Microbiology · doi:10.1099/mic.0.2006/004077-0 · Cited by 347
Filkins, L. M., Graber, J. A., Olson, D. G., Dolben, E. L., Lynd, L. R., Bhuju, S., & O'Toole, G. A. (2015) · Journal of Bacteriology · doi:10.1128/jb.00059-15 · Cited by 346
Early intervention and prevention of lung disease in cystic fibrosis: a European consensus
Döring, G., & Hoiby, N. (2004) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.03.008 · Cited by 304
Sibley, C. D., Duan, K., Fischer, C., Parkins, M. D., Storey, D. G., Rabin, H. R., & Surette, M. G. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000184 · Cited by 261
Pier, G. B., Coleman, F., Grout, M., Franklin, M., & Ohman, D. E. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1895-1901.2001 · Cited by 258
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung
Hogardt, M., & Heesemann, J. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.08.008 · Cited by 257
Ryan, R. P., Fouhy, Y., Garcia, B. F., Watt, S. A., Niehaus, K., Yang, L., Tolker‐Nielsen, T., & Dow, J. M. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06132.x · Cited by 232
Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005
Razvi, S., Quittell, L., Sewall, A., Quinton, H., Marshall, B., & Saiman, L. (2009) · Chest · doi:10.1378/chest.09-0132 · Cited by 225
Hill, D., Rose, B., Pajkos, A., Robinson, M., Bye, P., Bell, S., Elkins, M., Thompson, B., MacLeod, C., Aaron, S. D., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5085-5090.2005 · Cited by 213
Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis
Guss, A. M., Roeselers, G., Newton, I. L. G., Young, C. R., Klepac-Ceraj, V., Lory, S., & Cavanaugh, C. M. (2011) · The ISME Journal · doi:10.1038/ismej.2010.88 · Cited by 197
Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome
Sibley, C. D., Grinwis, M. E., Field, T. R., Eshaghurshan, C. S., Faria, M. M., Dowd, S. E., Parkins, M. D., Rabin, H. R., & Surette, M. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022702 · Cited by 195
Biswas, L., Biswas, R., Schlag, M., Bertram, R., & Götz, F. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01211-09 · Cited by 182
Respiratory bacterial infections in cystic fibrosis
Ciofu, O., Hansen, C. R., & Høiby, N. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835f1afc · Cited by 173
Anaerobic physiology of Pseudomonas aeruginosa in the cystic fibrosis lung
Schobert, M., & Jahn, D. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.08.007 · Cited by 166
Assessment of Airway Microbiota and Inflammation in Cystic Fibrosis Using Multiple Sampling Methods
Zemanick, E. T., Wagner, B. D., Robertson, C. E., Stevens, M. J., Szefler, S. J., Accurso, F. J., Sagel, S. D., & Harris, J. K. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201407-310oc · Cited by 159
Schertzer, J. W., Brown, S. A., & Whiteley, M. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07303.x · Cited by 159
Price, K. E., Hampton, T. H., Gifford, A. H., Dolben, E. L., Hogan, D. A., Morrison, H. G., Sogin, M. L., & O’Toole, G. A. (2013) · Microbiome · doi:10.1186/2049-2618-1-27 · Cited by 135
Hassett, D. J., Korfhagen, T. R., Irvin, R. T., Schurr, M. J., Sauer, K., Lau, G. W., Sutton, M. D., Yu, H. D., & Høiby, N. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903454988 · Cited by 131
Bragonzi, A., Farulla, I., Paroni, M., Twomey, K. B., Pirone, L., Lorè, N. I., Bianconi, I., Dalmastri, C., Ryan, R. P., & Bevivino, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052330 · Cited by 126
Furiga, A., Lajoie, B., Hage, S. E., Baziard-Mouysset, G., & Roques, C. G. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02533-15 · Cited by 123
Pompilio, A., Crocetta, V., Nicola, S. D., Verginelli, F., Fiscarelli, E. V., & Bonaventura, G. D. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00951 · Cited by 120
Macho, A. P., Zumaquero, A., Ortiz‐Martín, I., & Beuzón, C. R. (2007) · Molecular Plant Pathology · doi:10.1111/j.1364-3703.2007.00404.x · Cited by 111
Lopes, S. P., Ceri, H., Azevedo, N. F., & Pereira, M. O. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.04.020 · Cited by 100
Self-citationTwomey, K. B., O’Connell, O. J., McCarthy, Y., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2011.167 · Cited by 96
Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients
Bittar, F., & Rolain, J. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03236.x · Cited by 82
Microbial ecology and adaptation in cystic fibrosis airways
Yang, L., Jelsbak, L., & Molin, S. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02459.x · Cited by 80
Revealing the dynamics of polymicrobial infections: implications for antibiotic therapy
Rogers, G. B., Hoffman, L. R., Whiteley, M., Daniels, T. W. V., Carroll, M. P., & Bruce, K. D. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.04.005 · Cited by 72
Field, T. R., White, A. P., Elborn, J. S., & Tunney, M. M. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0031-9 · Cited by 67
Blau, H., Linnane, B. M., Carzino, R., Tannenbaum, E., Skoric, B., Robinson, P. J., ROBERTSON, C. F., & Ranganathan, S. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.05.013 · Cited by 61
King, P. A., Citron, D. M., Griffith, D. C., Lomovskaya, O., & Dudley, M. N. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.09.009 · Cited by 54
Chattoraj, S. S., Murthy, R., Ganesan, S., Goldberg, J. B., Zhao, Y., Hershenson, M. B., & Sajjan, U. S. (2010) · Infection and Immunity · doi:10.1128/iai.01192-09 · Cited by 38
The cystic fibrosis microbiome in an ecological perspective and its impact in antibiotic therapy
Magalhães, A. P., Azevedo, N. F., Pereira, M. O., & Lopes, S. P. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-7177-x · Cited by 37
Self-citationKadouri, D. E., & Tran, A. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.01193-13 · Cited by 28
Sriramulu, D. D. (2013) · Microbiology Insights · doi:10.4137/mbi.s10792 · Cited by 22
Cited by
Gut microbiome alterations in Alzheimer’s disease
Vogt, N. M., Kerby, R. L., Dill-McFarland, K. A., Harding, S. J., Merluzzi, A. P., Johnson, S. C., Carlsson, C. M., Asthana, S., Zetterberg, H., Blennow, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13601-y · Cited by 2,137
Azubuike, C. C., Chikere, C. B., & Okpokwasili, G. C. (2016) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-016-2137-x · Cited by 1,401
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Soil microbiome: a key player for conservation of soil health under changing climate
Dubey, A., Malla, M. A., Khan, F., Chowdhary, K., Yadav, S., Kumar, A., Sharma, S., Khare, P. K., & Khan, M. L. (2019) · Biodiversity and Conservation · doi:10.1007/s10531-019-01760-5 · Cited by 396
Diversity and function of prevalent symbiotic marine bacteria in the genus Endozoicomonas
Neave, M. J., Apprill, A., Ferrier-Pagès, C., & Voolstra, C. R. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7777-0 · Cited by 329
Metadata
- Authors
- Magalhães, A. P., Lopes, S. P., & Pereira, M. O.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-01-13
- Volume
- 7
- Pages
- 2146-2146
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2577653739
- Cited by
- 578
- References
- 47
- FWCI
- 35.91
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.